These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 25684493)
21. Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection. Chan KM; Kuo CF; Hsu JT; Chiou MJ; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Lee WC Liver Int; 2017 Mar; 37(3):434-441. PubMed ID: 27775209 [TBL] [Abstract][Full Text] [Related]
22. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis. Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371 [TBL] [Abstract][Full Text] [Related]
23. Metformin effects on biochemical recurrence and metabolic signaling in the prostate. Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966 [TBL] [Abstract][Full Text] [Related]
24. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
25. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis. Nie Z; Zhu H; Gu M Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666 [TBL] [Abstract][Full Text] [Related]
26. Metformin and prostate cancer mortality: a meta-analysis. Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119 [TBL] [Abstract][Full Text] [Related]
27. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis. Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522 [TBL] [Abstract][Full Text] [Related]
28. Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies. Yu H; Yin L; Jiang X; Sun X; Wu J; Tian H; Gao X; He X PLoS One; 2014; 9(12):e116327. PubMed ID: 25545701 [TBL] [Abstract][Full Text] [Related]
29. Association between metformin use and risk of prostate cancer and its grade. Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056 [TBL] [Abstract][Full Text] [Related]
30. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122 [TBL] [Abstract][Full Text] [Related]
31. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Zhang ZJ; Li S Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896 [TBL] [Abstract][Full Text] [Related]
32. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Yin M; Zhou J; Gorak EJ; Quddus F Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613 [TBL] [Abstract][Full Text] [Related]
33. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis. Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158 [TBL] [Abstract][Full Text] [Related]
34. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. Noto H; Goto A; Tsujimoto T; Noda M PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244 [TBL] [Abstract][Full Text] [Related]
35. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes. Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546 [TBL] [Abstract][Full Text] [Related]
36. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis. Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254 [TBL] [Abstract][Full Text] [Related]
37. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. Tseng CH Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464 [TBL] [Abstract][Full Text] [Related]
38. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis. He XK; Su TT; Si JM; Sun LM Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616 [TBL] [Abstract][Full Text] [Related]
39. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Nie SP; Chen H; Zhuang MQ; Lu M Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538 [TBL] [Abstract][Full Text] [Related]
40. Association of metformin use and cancer incidence: a systematic review and meta-analysis. O'Connor L; Bailey-Whyte M; Bhattacharya M; Butera G; Hardell KNL; Seidenberg AB; Castle PE; Loomans-Kropp HA J Natl Cancer Inst; 2024 Apr; 116(4):518-529. PubMed ID: 38291943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]